These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10962218

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D.
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
    Watanabe K, Miura I, Kanno-Nozaki K, Horikoshi S, Mashiko H, Niwa S, Yabe H.
    Psychiatry Res; 2015 Dec 15; 230(2):419-23. PubMed ID: 26416588
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
    Miller AL, Maas JW, Contreras S, Seleshi E, True JE, Bowden C, Castiglioni J.
    Biol Psychiatry; 1993 Aug 01; 34(3):178-87. PubMed ID: 8104509
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
    Magliozzi JR, Doran AR, Gietzen DW, Olson AM, Maclin EL, Tuason VB.
    Psychiatry Res; 1993 May 30; 47(2):141-9. PubMed ID: 8341767
    [Abstract] [Full Text] [Related]

  • 14. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M, van Kammen DP, Kelley ME, Yao J.
    Neuropsychopharmacology; 1996 Jul 30; 15(1):75-86. PubMed ID: 8797194
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL.
    Arch Gen Psychiatry; 1991 Jan 30; 48(1):73-6. PubMed ID: 1670618
    [Abstract] [Full Text] [Related]

  • 17. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.
    Wieselgren IM, Lindström LH.
    Psychiatry Res; 1998 Nov 16; 81(2):101-10. PubMed ID: 9858027
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.
    Mazure CM, Bowers MB.
    J Affect Disord; 1998 Feb 16; 48(1):83-6. PubMed ID: 9495606
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.